Editorial
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
- PMID: 17145593
Item in Clipboard
Editorial
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
Haematologica.
2006 Dec.
No abstract available
Similar articles
-
WPSS versus simplified myelodysplastic syndrome risk score: Which is the best tool for prediction of survival in myelodysplastic patients?Leuk Res. 2009 Jul;33(7):e93-4. doi: 10.1016/j.leukres.2008.10.027. Epub 2008 Dec 12. Leuk Res. 2009. PMID: 19070364 No abstract available.
-
Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.Acta Haematol. 2008;119(4):226-35. doi: 10.1159/000140675. Epub 2008 Jun 20. Acta Haematol. 2008. PMID: 18566541
-
Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.Eur J Haematol. 2008 Nov;81(5):364-73. doi: 10.1111/j.1600-0609.2008.01124.x. Epub 2008 Jul 10. Eur J Haematol. 2008. PMID: 18637029
-
[Myelodysplastic syndromes].Internist (Berl). 1998 Nov;39(11):1168-80. Internist (Berl). 1998. PMID: 9859051 Review. German. No abstract available.
-
Evolving classifications of the myelodysplastic syndromes.Curr Opin Hematol. 2007 Mar;14(2):98-105. doi: 10.1097/MOH.0b013e328017f633. Curr Opin Hematol. 2007. PMID: 17255786 Review.
Cited by
-
Current challenges and unmet medical needs in myelodysplastic syndromes.Leukemia. 2021 Aug;35(8):2182-2198. doi: 10.1038/s41375-021-01265-7. Epub 2021 May 28. Leukemia. 2021. PMID: 34045662 Free PMC article. Review.
-
Testosterone therapy as a novel approach to the management of cytopenias in myelodysplastic neoplasms: a review of literature and case report.J Cancer Res Clin Oncol. 2024 Aug 29;150(8):404. doi: 10.1007/s00432-024-05844-w. J Cancer Res Clin Oncol. 2024. PMID: 39207555 Free PMC article. Review.
-
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox.Front Oncol. 2021 Oct 6;11:752192. doi: 10.3389/fonc.2021.752192. eCollection 2021. Front Oncol. 2021. PMID: 34692534 Free PMC article. Review.
-
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.Haematologica. 2011 Mar;96(3):349-52. doi: 10.3324/haematol.2010.030023. Haematologica. 2011. PMID: 21357714 Free PMC article. No abstract available.
-
Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts.Leukemia. 2023 Nov;37(11):2314-2318. doi: 10.1038/s41375-023-02031-7. Epub 2023 Sep 26. Leukemia. 2023. PMID: 37752285 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical